₹21,804.05
(-4.29)
(-0.01%)
29 Aug , 2025 | 04:14 PM
Open
₹21,806.35
Prev. Close
₹21,808.35
Market Cap.
₹16,75,570.21
Div Yield
0.72
PE
31.63
PB
31.63
₹21,696.9
₹21,894.6
Performance
One Week (%)
-2.07
One Month (%)
-5.49
One Year (%)
-4.69
YTD (%)
4.96
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 31,480 | 31,945 | 31,315 | 4,571 |
Cipla Ltd | 1,589.4 | 1,596.4 | 1,567.8 | 13,42,344 |
J B Chemicals & Pharmaceuticals Ltd | 1,724.3 | 1,729 | 1,705.4 | 1,45,296 |
Dr Reddys Laboratories Ltd | 1,260.1 | 1,266.4 | 1,240.8 | 24,22,956 |
Lupin Ltd | 1,894.9 | 1,917.7 | 1,890 | 8,65,960 |
Torrent Pharmaceuticals Ltd | 3,559.8 | 3,607.6 | 3,553.3 | 2,79,287 |
Ipca Laboratories Ltd | 1,384.4 | 1,414.8 | 1,380.2 | 1,56,601 |
Sun Pharmaceutical Industries Ltd | 1,594.5 | 1,601.7 | 1,575.8 | 31,76,534 |
Aurobindo Pharma Ltd | 1,027.9 | 1,040.1 | 1,020 | 8,82,168 |
Natco Pharma Ltd | 862 | 872 | 855.55 | 2,44,492 |
Granules India Ltd | 492.25 | 512.9 | 467.9 | 1,69,43,450 |
Ajanta Pharma Ltd | 2,477.6 | 2,529.8 | 2,449.6 | 3,51,127 |
Gland Pharma Ltd | 1,871.5 | 1,904 | 1,852.6 | 1,40,575 |
Biocon Ltd | 348.35 | 356.1 | 347.15 | 18,10,109 |
Alkem Laboratories Ltd | 5,303.5 | 5,388 | 5,291 | 1,15,288 |
Glenmark Pharmaceuticals Ltd | 1,923.9 | 1,947.8 | 1,910.7 | 2,39,914 |
Zydus Lifesciences Ltd | 981.05 | 988.5 | 969.2 | 8,33,114 |
Divis Laboratories Ltd | 6,131.5 | 6,177.5 | 6,092 | 2,83,850 |
Mankind Pharma Ltd | 2,471.4 | 2,511.3 | 2,455.1 | 3,30,123 |
Laurus Labs Ltd | 856.9 | 872.6 | 854.75 | 6,46,790 |
The IPO of Jio is expected to be one of the most closely watched listings in India’s capital markets, marking the next major milestone for Reliance in unlocking value across its businesses.
30 Aug 2025|12:40 PM
On the other hand, revenue rose 12.2% in Q2 CY25 to ₹3,175.4 crore, compared with ₹2,831 crore in the corresponding quarter of the previous fiscal.
30 Aug 2025|12:34 PM
Nishant, who has been part of the company’s board since 2008, was re-appointed to the board for a five-year term in May 2024.
30 Aug 2025|12:21 PM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
